Trial Profile
Superiority comparative test of conventional treatment vs naldemedine for prevention of opioid-induced constipation in cancer patients: Investigator initiated, single center, 2 arm, open label, randomized controlled trials
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 May 2021
Price :
$35
*
At a glance
- Drugs Naldemedine (Primary) ; Magnesium oxide
- Indications Constipation
- Focus Registrational; Therapeutic Use
- 25 May 2021 Masking changed from double-blind to open-label.
- 23 Oct 2020 Planned End Date changed from 21 Mar 2023 to 30 Jun 2019.
- 23 Oct 2020 Status changed from recruiting to active, no longer recruiting.